These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25446513)

  • 81. Dissolving Microneedles Loaded with Gestodene: Fabrication and Characterization In Vitro and In Vivo.
    Duan X; Ma J; Ning M; Gao Y
    Iran J Pharm Res; 2023; 22(1):e131819. PubMed ID: 38116561
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications.
    Lee DH; Lim S; Kwak SS; Kim J
    Adv Healthc Mater; 2024 Mar; 13(7):e2302375. PubMed ID: 38009520
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transdermal Delivery of Metformin Using Dissolving Microneedles and Iontophoresis Patches for Browning Subcutaneous Adipose Tissue.
    Abbasi M; Fan Z; Dawson JA; Wang S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456713
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficient Drug Delivery into Skin Using a Biphasic Dissolvable Microneedle Patch with Water-Insoluble Backing.
    Li S; Xia D; Prausnitz MR
    Adv Funct Mater; 2021 Oct; 31(44):. PubMed ID: 34744551
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dissolving Polymer Microneedles for Transdermal Delivery of Insulin.
    Zhang N; Zhou X; Liu L; Zhao L; Xie H; Yang Z
    Front Pharmacol; 2021; 12():719905. PubMed ID: 34630098
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs.
    Liu T; Chen M; Fu J; Sun Y; Lu C; Quan G; Pan X; Wu C
    Acta Pharm Sin B; 2021 Aug; 11(8):2326-2343. PubMed ID: 34522590
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Non-dermal applications of microneedle drug delivery systems.
    Panda A; Matadh VA; Suresh S; Shivakumar HN; Murthy SN
    Drug Deliv Transl Res; 2022 Jan; 12(1):67-78. PubMed ID: 33629222
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
    Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
    AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effective Dispensing Methods for Loading Drugs Only to the Tip of DNA Microneedles.
    Bok M; Zhao ZJ; Hwang SH; Kang HJ; Jeon S; Ko J; Jeong J; Song YS; Lim E; Jeong JH
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33050428
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Current trends in polymer microneedle for transdermal drug delivery.
    Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
    Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Engineering Microneedles for Therapy and Diagnosis: A Survey.
    Xie L; Zeng H; Sun J; Qian W
    Micromachines (Basel); 2020 Mar; 11(3):. PubMed ID: 32150866
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A novel scalable fabrication process for the production of dissolving microneedle arrays.
    Chen H; Wu B; Zhang M; Yang P; Yang B; Qin W; Wang Q; Wen X; Chen M; Quan G; Pan X; Wu C
    Drug Deliv Transl Res; 2019 Feb; 9(1):240-248. PubMed ID: 30341765
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Synergistic immunoreaction of acupuncture-like dissolving microneedles containing thymopentin at acupoints in immune-suppressed rats.
    Zhang Q; Xu C; Lin S; Zhou H; Yao G; Liu H; Wang L; Pan X; Quan G; Wu C
    Acta Pharm Sin B; 2018 May; 8(3):449-457. PubMed ID: 29881684
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Recent advances of controlled drug delivery using microfluidic platforms.
    Sanjay ST; Zhou W; Dou M; Tavakoli H; Ma L; Xu F; Li X
    Adv Drug Deliv Rev; 2018 Mar; 128():3-28. PubMed ID: 28919029
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Microfabrication for Drug Delivery.
    Koch B; Rubino I; Quan FS; Yoo B; Choi HJ
    Materials (Basel); 2016 Aug; 9(8):. PubMed ID: 28773770
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
    González-Vázquez P; Larrañeta E; McCrudden MTC; Jarrahian C; Rein-Weston A; Quintanar-Solares M; Zehrung D; McCarthy H; Courtenay AJ; Donnelly RF
    J Control Release; 2017 Nov; 265():30-40. PubMed ID: 28754611
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug Delivery.
    Wang QL; Zhu DD; Liu XB; Chen BZ; Guo XD
    Sci Rep; 2016 Dec; 6():38755. PubMed ID: 27929104
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.
    Alkilani AZ; McCrudden MT; Donnelly RF
    Pharmaceutics; 2015 Oct; 7(4):438-70. PubMed ID: 26506371
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transdermal Delivery of Drugs with Microneedles-Potential and Challenges.
    Ita K
    Pharmaceutics; 2015 Jun; 7(3):90-105. PubMed ID: 26131647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.